LOW BIOAVAILABILITY OF CYCLOSPORINE MICROEMULSION AND TACROLIMUS IN A SMALL BOWEL TRANSPLANT RECIPIENT
Bruce Kaplan(Saint Barnabas Medical Center), Jonathan P. Fryer(Northwestern University), Dixon B. Kaufman(University of Wisconsin–Madison), Ken Lown(University of Michigan), Joseph R. Leventhal(Northwestern Memorial Hospital), Robert M. Craig(Northwestern University), Herwig‐Ulf Meier‐Kriesche(University of Florida), Michaël Abécassis(University of Arizona), Frank P. Stuart(Northwestern University)
Cited by 54
Related Papers
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
|Hepatology|2018|4.7k
AASLD guidelines for the treatment of hepatocellular carcinoma
|Hepatology|2017|4.2k
The International Position on Laparoscopic Liver Surgery
|Annals of Surgery|2009|1.5k
Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors
|Liver Transplantation|2010|1.2k